Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study

•The DRS-P scale can distinguish ovarian cancer changes in health status with disease progression versus stabilization.•The DRS-P scale can identify ovarian cancer changes in health status that are distinct from treatment side effects.•The DRS-P can capture symptoms and functional aspects of the natural history of advancing ovarian cancer.•Assessment completion and survival time are highly correlated.